Previously reported thyroxine screening methods are hampered at the bound-free separation step. Utilizing anion-exchange resin (4), a second antibody (5), or dextrancoated charcoal (6), these systems involve at least two pipetting steps and a centrifugation, and with some methods, the thyroxine must be extracted from the filter paper before the assay. These laborious, time-consuming techniques are not readily adaptable to total automation. The following studies were done to test the adaptability of the hnmunotube5 T4 assay (SmithKllne Instruments, Inc.) to neonatal thyroxine screening. These samples were shipped on solid CO2 within a week of specimen collection and stored at -15 #{176}C until assayed.
Material and Methods

Equipment
Methods
Liquid serum assay: Serum sample or standard, 20 d, was pipetted into the antibody-coated tube, followed by 2 ml of the assay buffer containing I'-labeled thyroxine.
After a 1-h incubation at room temperature, bound and free thyroxine punched from the spots and tested in the dried blood assay. 20 139 4.3 3.1
Corresponding serum samples were tested in the liquid serum assay. In addition, we compared hypothyroid serum and blood samples with values ranging from 10 to 40 iig/liter by using 0.64-cm discs. The correlation in all three studies was excellent (Table 2) .
Precision studies: Table 3 shows the results of replicate determinations within each of the assay systems, including the liquid serum assay. For samples of several different concentrations the disc assays show an intra-assay coefficient of variation ranging from 8.1 to 9.8%. Since the Immunotube liquid serum assay typically shows coefficients of variation in the range of 3 to 4% at both normal and abnormal concentrations, it can be assumed that the greater imprecision in the dried blood assays is due to inconsistencies in the filter paper, the spotting of the samples, or the punching of the discs.
Studies of neonatal blood samples:
We obtained 350 neonatal blood samples from the State of New York Department of Health to test in the Immunotube assay. The samples were run in duplicate and divided among eight assays. Figure 1 shows the distribution of the thyroxine values for these sam- 
Table 3. Results of Precision Studies
were separated by aspirating the contents of the tube. These tubes were then transferred to the gamma counter, which calculated and printed out the values for the unknown samples.
Dried blood assay: When we used blood samples, the disc containing the dried serum standard or blood sample was placed directly into the antibody tube, followed by the assay buffer containing I125-labeled thyroxine-i ml for a 0.64-cm disc assay or 0.5 ml for a 0.32-cm disc assay. The tubes were incubated for 2 h at 37 #{176}C, the disc and buffer were aspirated, and the tubes then placed in the gamma counter. Because the standards were made up of serum, the values for the unknown samples obtained from the standard curve were then corrected for their respective hematocrits. For the neonatal samples, a hematocrit of 50% was assumed.
Results and Discussion
Elution of blood from filter paper: It was necessary to determine if all the thyroxine in a dried blood sample could be of the values in these assays. An additional 27 hypothyroid neonatal samples were run in each assay system (Table 4) . Using 1.5 standard deviations below the mean as a statistical cutoff point, we detected 26 of the 27 hypothyroid samples in the Immunotube assay. The samples were run singly, and the one sample that was not detected in our assay was subsequently found to be normal.
The For the Immunotube assay, the samples are run singly, with use of 0.32-cm discs; any sample with a value less than 1.5 standard deviations below that day's mean is repeated in duplicate the next day. For this statistical analysis, samples are divided into two groups, based on the age of the infant when the sample was taken. The first group of infants are those less than seven days of age, with an average of three days. To date, these samples have had a mean thyroxine value of 132 ag/liter, with a cut-off value for repeated samples of 92 ig/liter. The second group of infants are those seven days of age or older. Most of these are follow-up samples, with an average age of 3.5 weeks. The mean value for this older group is 92 pg/liter, with a cutoff value of 58 pg/liter. Samples that are suspect (about a third of those repeated in duplicate) are assayed for thyrotropin, and, if found to be abnormal, the hospital or pediatrician from whom the suspect sample was received is informed.
After performing the necessary testing of the patient, the physician reports the results back to the State Laboratory.
With use of the above method, 30 392 screening tests have been performed, 2950 (9.7%) of these samples being repeated in duplicate. Thyrotropin assays have been performed on 829 (2.7%) samples. To date, nine confirmed cases of primary congenital hypothyroidism have been reported back to the State Laboratory.
Of these nine cases confirmed, five had initial thyroxine values, on screening, of less than 25 zg/liter. The remaining four had values of 40, 44, 60, and 70 gfliter. All had thyrotropin values greater than 179 milliunits/liter (normal value, less than 20). In most cases, the time interval between birth and final confirmation has been less than one month.
We conclude that the Immunotube T4 assay can be used with blood samples on filter paper, such as those now in use for screening. The assay can be mechanized when used with the Punch Indexer (Fundamental Products Co., North Hollywood, Calif. 91601), which currently is used in several laboratories for phenylketonuria screening. Discs 0.32 cm in diameter are punched out and can be simultaneously delivered to the antibody tubes and to the agar trays used in phenylketonuria testing.
The "University Model" punch indexer will also deliver 0.5 ml of buffer to each tube, after dropping in the specimen disc.
Our assay provides a screening method for neonates that is accurate, versatile, and easily automated, all important features for a large-scale screening program. The assay components are commercially available from SmithKline Instruments, Inc. 
